Summary & Overview
Spinal Fusion Except Cervical with Spinal Curvature, Malignancy, Infection or Extensive Fusions without CC/MCC: Inpatient Reimbursement Overview
DRG 458 addresses non-cervical spinal fusion procedures associated with spinal curvature, malignancy, infection, or extensive fusion when there is no Major Complication or Comorbidity; it defines the inpatient clinical scope and case mix for payment. This Diagnosis-Related Group matters for inpatient reimbursement because it determines the bundled payment level and reflects resource use for complex fusion surgeries without Major Complication or Comorbidity.
DRG 458 Overview
DRG 458 covers inpatient admissions for posterior and other spinal fusion procedures excluding the cervical region when the case involves spinal curvature, malignancy, infection, or extensive fusion without a Major Complication or Comorbidity. This Diagnosis-Related Group aggregates higher-resource fusion surgeries that do not meet Major Complication or Comorbidity criteria but still have increased clinical complexity. It matters for Medicare payment because the grouping affects base reimbursement and resource-intensity classification for inpatient stays. Accurate coding of the underlying spinal pathology and the absence of Major Complication or Comorbidity is essential to proper assignment to this Diagnosis-Related Group.
Clinical Trials
- Perioperative optimization and enhanced recovery protocols for extensive thoracolumbar spinal fusion: randomized or pragmatic trials testing multimodal pathways (including blood management, infection prevention bundles, and standardized analgesia) for adult patients undergoing non-cervical spinal fusion for deformity, malignancy, infection, or multilevel constructs. These studies focus on the immediate inpatient period to reduce operative blood loss, transfusion needs, length of stay, and surgical site complications in a high-risk, often older or medically complex population. Results inform providers about care processes that can decrease complications and inform payers about potential cost savings and readmission risk reductions associated with standardized perioperative care.
- Comparative effectiveness research on surgical approaches and fusion extent for spinal deformity and tumor-related fusion: prospective cohort studies or randomized trials comparing posterior-only versus combined anterior-posterior approaches, different instrumentation strategies, or varying fusion levels in patients with spinal curvature, neoplastic involvement, or extensive fusions without CC/MCC. These studies enroll patients whose pathologies require non-cervical fusion and evaluate outcomes such as fusion success, neurologic function, reoperation rates, and in-hospital resource use. Findings help surgeons and hospital administrators select approaches that balance clinical benefit with operative time, implant costs, and complication profiles important for DRG-based reimbursement and resource planning.
- Post-discharge functional outcomes, rehabilitation needs, and long-term resource utilization studies: longitudinal observational studies or registry analyses tracking functional recovery, pain control, discharge disposition (home vs. rehab/SNF), and subsequent healthcare utilization for patients after non-cervical extensive spinal fusion for deformity, infection, or malignancy. These studies target the subpopulation at risk for prolonged rehabilitation needs, recurrent admissions, or durable disability and measure metrics like time to independent ambulation, need for durable medical equipment, and post-acute care costs. Data guide case management, discharge planning practices, and payer strategies for bundled payments by identifying predictors of high post-discharge costs and modifiable factors to improve outcomes and reduce readmissions.
Trek Health ingests and normalizes Transparency in Coverage data and payer policy updates to give provider organizations a clear view of how commercial reimbursement behaves across markets, payers, and services. Our platform transforms raw payer disclosures into structured intelligence that supports contract evaluation, payer negotiations, and service line strategy. By combining market benchmarks with ongoing policy visibility, Trek helps teams identify variability, risk, and opportunity in commercial reimbursement. The result is faster insight, stronger negotiating positions, and more informed financial decisions.